VOSPIRE ER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vospire Er, and what generic alternatives are available?
Vospire Er is a drug marketed by Strides Pharma and is included in one NDA.
The generic ingredient in VOSPIRE ER is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vospire Er
A generic version of VOSPIRE ER was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.
Summary for VOSPIRE ER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 81 |
Clinical Trials: | 6 |
Patent Applications: | 5,573 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VOSPIRE ER at DailyMed |
Recent Clinical Trials for VOSPIRE ER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
VA Office of Research and Development | Phase 4 |
ALK-Abelló A/S | Phase 3 |
Merck Sharp & Dohme Corp. | Phase 3 |
US Patents and Regulatory Information for VOSPIRE ER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Strides Pharma | VOSPIRE ER | albuterol sulfate | TABLET, EXTENDED RELEASE;ORAL | 076130-002 | Sep 26, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Strides Pharma | VOSPIRE ER | albuterol sulfate | TABLET, EXTENDED RELEASE;ORAL | 076130-003 | Sep 26, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |